Dr. Sharon Walmsley, who experienced the devastating impact of the HIV/AIDS epidemic firsthand in the 1980s, is now leading groundbreaking research at Toronto General Hospital. One of her patients, known as the “Toronto patient,” is on the path to becoming the first Canadian cured of HIV. This 62-year-old man was diagnosed with HIV in 1999 and received antiretroviral therapy to control the virus. In 2021, he developed a severe blood cancer and underwent chemotherapy along with a bone marrow transplant, a treatment that has reportedly cured a small number of HIV patients worldwide.
While this case shows promising results, it is a complex and risky procedure that is only suitable for a select few individuals who meet specific criteria. The patient’s recovery has ignited hope for a broader cure for HIV. By receiving donor cells with a rare genetic mutation and undergoing myeloablative conditioning, his immune system was essentially reset, leading to undetectable HIV levels after stopping antiretroviral therapy in 2025. If this trend continues for approximately another 20 months, he may be considered cured.
However, Dr. Walmsley and other experts caution that such treatment is not suitable for most HIV patients due to its invasiveness and associated risks. The cost of this specialized treatment is around $300,000 in Canada, making it financially out of reach for many. While this milestone is significant, the focus remains on developing more accessible and less complicated solutions to combat HIV.
Adam Castillejo, the “London patient” who was the second person globally considered cured of HIV, welcomes the Toronto patient to the small group of individuals who have achieved this feat. Castillejo encourages others to remain hopeful, as scientists continue to work tirelessly towards finding a cure that is viable for all.